Cargando…
MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A
Osteosarcoma (OS), the most common malignant bone tumor, is the main cause of cancer-related deaths in children and young adults. Despite the combination of surgery and multi-agent chemotherapy, patients with OS who develop resistance to chemotherapy or experience recurrence have a dismal prognosis....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620383/ https://www.ncbi.nlm.nih.gov/pubmed/31221814 http://dx.doi.org/10.1042/BSR20190198 |